We use cookies to improve the performance of our site and optimize it for our users. Customize Cookie Preferences

Sign Up Today and Learn More About Clarapath Stock

Invest in or calculate the value of your shares in Clarapath or other pre-IPO companies through EquityZen's platform.

Get Started

Clarapath Stock (CLAR)

Clarapath is a medical robotics company that develops the SectionStar, a platform to mimic the human histotechnician.

About Clarapath Stock

Founded

2014

Headquarters

New York, NY, US

Industries

Software, Artificial Intelligence, Data and Analytics

Clarapath is a medical robotics company automating the laboratory. The company's first product is focused on fully automating the microtomy station in pathology. Their vision is to innovate, standardize, and digitally transform anatomic pathology through higher-quality lab medicine, more robust safety standards, and increased lab throughput while lowering laboratory costs and labor-related delays. Their next-generation laboratory at the NY Genome Center together with our large-scale image repository and analysis platform are designed to handle the entire “tissue to bits” pipeline for special research projects as well as larger-scale clinical needs. Clarapath works closely with both research and clinical customers to produce faster, more accurate results.

Clarapath Press Mentions

Stay in the know about the latest news on Clarapath

Clarapath Management

Leadership team at Clarapath

Board Observer

David Eigen

Director of Finance and Human Resources

Kavita Sethi

Locked Features

Join now and verify your accreditation status to gain access to:

  • Clarapath current valuation
  • Clarapath stock price
  • Available deals in Clarapath and all other companies
  • Deal offering documents
  • EquityZen's proprietary data and insights, including
    • Cap tables, which include funding history by Share Class and Liquidity Preferences
    • Company Highlights
    • Business Model
    • Risk Factors
Join Now

How to invest in Clarapath stock?

Accredited investors can buy pre-IPO stock in companies like Clarapath through EquityZen funds. These investments are made available by existing Clarapath shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.

How to sell Clarapath stock?

Shareholders can sell their Clarapath stock through EquityZen's private company marketplace. EquityZen's network includes over 330K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.

If I invest, how do I exit my investment?

There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.

Why choose EquityZen?

Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 43K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."